Patents Assigned to Absynth Biologics Ltd.
  • PheP, an amino acid permease of
    Patent number: 8168204
    Abstract: The present invention relates to antigenic polypeptides expressed by pathogenic microbes, including antigenic polypeptides encoded by the nucleic acid sequence of FIG. 1, vaccines comprising the antigenic polypeptides and therapeutic antibodies directed to the antigenic polypeptides.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: May 1, 2012
    Assignee: Absynth Biologics Ltd.
    Inventor: Simon J. Foster
  • PHEP, AN AMINO ACID PERMEASE OF STAPHYLOCOCCUS AUREUS
    Publication number: 20110171237
    Abstract: The present invention relates to antigenic polypeptides expressed by pathogenic microbes, including antigenic polypeptides encoded by the nucleic acid sequence of FIG. 1, vaccines comprising the antigenic polypeptides and therapeutic antibodies directed to the antigenic polypeptides.
    Type: Application
    Filed: April 23, 2010
    Publication date: July 14, 2011
    Applicant: ABSYNTH BIOLOGICS LTD.
    Inventor: Simon J. FOSTER
  • Phep, an amino acid permease of
    Patent number: 7740869
    Abstract: The present invention relates to antigenic polypeptides expressed by pathogenic microbes, including antigenic polypeptides encoded by the nucleic acid sequence of FIG. 1, vaccines comprising the antigenic polypeptides and therapeutic antibodies directed to the antigenic polypeptides.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: June 22, 2010
    Assignee: Absynth Biologics Ltd.
    Inventor: Simon J. Foster